AI assistant
ARTIVION, INC. — Director's Dealing 2021
May 27, 2021
31684_dirs_2021-05-27_55b6014b-6b99-4b4b-90e5-c06f9cfb3114.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2021-05-25
Reporting Person: Davis John E (Senior VP, Global Sales)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-25 | Common Stock | S | 5402 | $29.6695 | Disposed | 79236 | Direct |
| 2021-05-25 | Common Stock | S | 880 | $29.6989 | Disposed | 78356 | Direct |
| 2021-05-25 | Common Stock | S | 6457 | $29.6531 | Disposed | 71899 | Direct |
| 2021-05-25 | Common Stock | M | 5402 | $26.24 | Acquired | 84638 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-25 | Stock Options (Right To buy) | $26.24 | M | 5402 | Disposed | 2027-02-19 | Common Stock (5402) | Direct |
Footnotes
F1: Reflects weighted average price. Range of prices were between $29.47 to $30.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Reflects weighted average price. Range of prices were between $29.47 to $30.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects weighted average price. Range of prices were between $29.44 to $30.135. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2021